Literature DB >> 34196120

LRRK2 recruitment, activity, and function in organelles.

Luis Bonet-Ponce1, Mark R Cookson1.   

Abstract

Protein coding mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial Parkinson's disease (PD), and noncoding variations around the gene increase the risk of developing sporadic PD. It is generally accepted that pathogenic LRRK2 mutations increase LRRK2 kinase activity, resulting in a toxic hyperactive protein that is inferred to lead to the PD phenotype. LRRK2 has long been linked to different membrane trafficking events, but the specific role of LRRK2 in these events has been difficult to resolve. Recently, several papers have reported the activation and translocation of LRRK2 to cellular organelles under specific conditions, which suggests that LRRK2 may influence intracellular membrane trafficking. Here, we review what is known about the role of LRRK2 at various organelle compartments. Published 2021. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  endomembranes; leucine-rich repeat kinase 2; lysosome; membrane trafficking; neurodegeneration; parkinson’s disease

Year:  2021        PMID: 34196120      PMCID: PMC8744135          DOI: 10.1111/febs.16099

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.622


  146 in total

1.  Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation.

Authors:  Jaerak Chang; Seongju Lee; Craig Blackstone
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 2.  Transport according to GARP: receiving retrograde cargo at the trans-Golgi network.

Authors:  Juan S Bonifacino; Aitor Hierro
Journal:  Trends Cell Biol       Date:  2010-12-21       Impact factor: 20.808

3.  Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages.

Authors:  Kohichi Matsunaga; Tatsuya Saitoh; Keisuke Tabata; Hiroko Omori; Takashi Satoh; Naoki Kurotori; Ikuko Maejima; Kanae Shirahama-Noda; Tohru Ichimura; Toshiaki Isobe; Shizuo Akira; Takeshi Noda; Tamotsu Yoshimori
Journal:  Nat Cell Biol       Date:  2009-03-08       Impact factor: 28.824

4.  A neurodevelopmental disorder caused by mutations in the VPS51 subunit of the GARP and EARP complexes.

Authors:  David C Gershlick; Morié Ishida; Julie R Jones; Allison Bellomo; Juan S Bonifacino; David B Everman
Journal:  Hum Mol Genet       Date:  2019-05-01       Impact factor: 6.150

5.  The GARP Complex Is Involved in Intracellular Cholesterol Transport via Targeting NPC2 to Lysosomes.

Authors:  Jian Wei; Ying-Yu Zhang; Jie Luo; Ju-Qiong Wang; Yu-Xia Zhou; Hong-Hua Miao; Xiong-Jie Shi; Yu-Xiu Qu; Jie Xu; Bo-Liang Li; Bao-Liang Song
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

6.  Dual roles of the mammalian GARP complex in tethering and SNARE complex assembly at the trans-golgi network.

Authors:  F Javier Pérez-Victoria; Juan S Bonifacino
Journal:  Mol Cell Biol       Date:  2009-07-20       Impact factor: 4.272

Review 7.  Sorting of lysosomal proteins.

Authors:  Thomas Braulke; Juan S Bonifacino
Journal:  Biochim Biophys Acta       Date:  2008-11-12

Review 8.  Lysosomes as dynamic regulators of cell and organismal homeostasis.

Authors:  Andrea Ballabio; Juan S Bonifacino
Journal:  Nat Rev Mol Cell Biol       Date:  2019-11-25       Impact factor: 94.444

9.  A novel Rab10-EHBP1-EHD2 complex essential for the autophagic engulfment of lipid droplets.

Authors:  Zhipeng Li; Ryan J Schulze; Shaun G Weller; Eugene W Krueger; Micah B Schott; Xiaodong Zhang; Carol A Casey; Jun Liu; Jacqueline Stöckli; David E James; Mark A McNiven
Journal:  Sci Adv       Date:  2016-12-16       Impact factor: 14.136

10.  An integrated transcriptomics and proteomics analysis reveals functional endocytic dysregulation caused by mutations in LRRK2.

Authors:  Natalie Connor-Robson; Heather Booth; Jeffrey G Martin; Benbo Gao; Kejie Li; Natalie Doig; Jane Vowles; Cathy Browne; Laura Klinger; Peter Juhasz; Christine Klein; Sally A Cowley; Paul Bolam; Warren Hirst; Richard Wade-Martins
Journal:  Neurobiol Dis       Date:  2019-04-05       Impact factor: 5.996

View more
  4 in total

1.  Novel N-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-06-21       Impact factor: 4.632

2.  2-Aminoquinazolines as LRRK2 Inhibitors for Treating Parkinson's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-04-22       Impact factor: 4.632

3.  LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's disease.

Authors:  Maria Kedariti; Emanuele Frattini; Pascale Baden; Susanna Cogo; Laura Civiero; Elena Ziviani; Gianluca Zilio; Federico Bertoli; Massimo Aureli; Alice Kaganovich; Mark R Cookson; Leonidas Stefanis; Matthew Surface; Michela Deleidi; Alessio Di Fonzo; Roy N Alcalay; Hardy Rideout; Elisa Greggio; Nicoletta Plotegher
Journal:  NPJ Parkinsons Dis       Date:  2022-07-19

Review 4.  Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson's Disease.

Authors:  José Ángel Martínez-Menárguez; Emma Martínez-Alonso; Mireia Cara-Esteban; Mónica Tomás
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.